ALPS Advisors »

Eliem Therapeutics shares owned by ALPS Advisors

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $758k 58k 13.04

More positions owned by ALPS Advisors

Energy Transfer Com Ut Ltd Ptn (ET)
Sunoco Lp/sunoco Fin Corp Com Ut Rep Lp (SUN)
MPLX Com Unit Rep Ltd (MPLX)
Enterprise Products Partners (EPD)
Western Midstream Partners L Com Unit Lp Int (WES)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Hess Midstream Cl A Shs (HESM)
Cheniere Energy Partners Com Unit (CQP)
Usa Compression Partners Com Unit Ltdpar (USAC)
Cameco Corporation (CCJ)
Genesis Energy Unit Ltd Partn (GEL)
Waterbridge Infrastructure L Cl A Shs Repstg (WBI)
Global Partners Com Units (GLP)
Suburban Propane Partners L Unit Ltd Partn (SPH)
Nexgen Energy (NXE)

View all positions for ALPS Advisors

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics